经皮双心室Impella支持治疗难治性心源性休克。
Percutaneous biventricular Impella support in therapy-refractory cardiogenic shock.
作者信息
Chiu Cheng-Ying, Hättasch Robert, Praeger Damaris, Knebel Fabian, Stangl Karl, Ramirez Ivan Diaz, Dreger Henryk
机构信息
Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Department of Cardiology and Angiology, Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany.
Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Department of Cardiology and Angiology, Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany.
出版信息
Heart Lung. 2018 May-Jun;47(3):250-252. doi: 10.1016/j.hrtlng.2018.03.009. Epub 2018 Apr 5.
INTRODUCTION
Percutaneous mechanical circulatory support systems have increasingly been adopted as a bail out strategy in patients with cardiogenic shock. Since studies showed mostly mixed results, however, the use of support systems remains a case by case decision.
CASE
Here, we report on a case of therapy-refractory cardiogenic shock due to acute myocardial infarction treated with percutaneous right and left ventricular assist devices (Impella RP and CP).
CONCLUSION
Due to myocardial stunning, even patients with fulminant cardiogenic shock have the potential for full recovery. In the present case, we demonstrate the feasibility of biventricular Impella support in therapy-refractory cardiogenic shock facilitating bridge to recovery.
引言
经皮机械循环支持系统越来越多地被用作心源性休克患者的一种补救策略。然而，由于研究结果大多参差不齐，支持系统的使用仍然需要根据具体情况决定。
病例
在此，我们报告一例因急性心肌梗死导致的治疗难治性心源性休克患者，采用经皮右心室和左心室辅助装置（Impella RP和CP）进行治疗。
结论
由于心肌顿抑，即使是暴发性心源性休克患者也有完全康复的可能。在本病例中，我们证明了双心室Impella支持在治疗难治性心源性休克中促进恢复桥梁的可行性。
Zotero 插件